Contribution of 18FDG PET/CT post treatment surveillance of head and neck squamous cell carcinoma;Intérêt de la TEP au 18FDG couplée à la TDM dans la surveillance post-thérapeutique des carcinomes épidermoïdes des voies aérodigestives supérieures

Annales d'Oto-Laryngologie et de Chirurgie Cervico-Faciale

Volumn 123, Issue 4, 2006, Pages 167-174

  Fakhry, N ^a   Barberet, M ^a   Paris, J ^a   Jacob, T ^a   Deveze, A ^a   Mundler, O ^a   Giovanni, A ^a   Zanaret, M ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

Cancer; FDG PET; Head and neck; Surveillance; Upper aero digestive tract

Indexed keywords

EID: 33748888912     PISSN: 0003438X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0003-438x(06)76661-0     Document Type: Article

References (25)

1. LONNEUX M. Progrès en imagerie des tumeurs de la sphère cervico-maxillofaciale : la tomographie par émission de positons (TEP-Scan). Cancer/Radiothérapie 2005;9:8-15.
2. WONG WI, HUSSAIN K, CHEVRETTON E, et al. Validation and clinical application of computer-combined computed tomography an positron emission tomography with 2-[ 18F] fluoro-2-deoxy-D-glucose head and neck images. Am J Surg 1996;172:628-32.
3. LAUBENBACHER C, SAUMWEBER D, WAGNER-MANSLAU C, et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI, and endoscopy for staging head neck squamous cell carcinomas. J Nucl Med 1995;36:1747-57.
4. RYAN Wr, FEE We, LE Qt, et al. Positron-emission tomography for surveillance of head and neck cancer. Laryngoscope 2005;115:645-50.
5. RD, et al. PET scanning in head and neck oncology: a review. Head Neck 1998;20:208-15.
6. PAULUS P, SAMBON A, VIVEGNIS D, et al. 18FDG-PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patients. Laryngoscope 1998;108:1578-83.
7. FARBER La, BERNARD F, MACHTAY M, et al. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy- D-glucose positron emission tomography. Laryngoscope 1999;109:970-5.
8. LONNEUX M, LAWSON G, IDE C, et al. Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient. Laryngoscope 2000;110:1493-7.
9. LOWE Vj, BOYD Jh, DUNPHY Fr, et al. Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol 2000;18:651-8.
10. LI P, ZHUANG H, MOZLEY Pd, et al. Evaluation of recurrent squamous cell carcinoma of the head and neck with FDG positron emission tomography. Clin Nucl Med 2001;26:131-5.
11. WONG Rj, LIN Dt, SCHODER H, et al. Diagnostic and prognostic value of [(18)F] fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 2002;20:4199-208.
12. BOURGUET P, et al. SOR Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in cancer of the upper aerodigestive tract. Bull Cancer 2003;90:S67-79.
13. GOERRES Gw, SCHMID Dt, BANDHAUER F, et al. Positron emission tomography in the early follow-up of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 2004;130:105-9.
14. WARE Re, MATTHEWS Jp, HICKS Rj et al. Usefulness of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with a residual structural abnormality after definitive treatment for squamous cell carcinoma of the head and neck. Head Neck 2004;26:1008-17.
15. TERHAARD Ch, BONGERS V, VAN RIJK Pp, et al. F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/ pharyngeal cancer. Head Neck 2001;23:933-41.
16. CONESSA C, HERVE S, FOEHRENBACH H, et al. FDG-PET scan in local follow-up of irradiated head and neck squamous cell carcinomas. Ann Otol Rhinol Laryngol 2004;113:628-35.
17. KITAGAWA Y, NISHIZAWA S, SANO K, et al. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma. J Nucl Med 2003;44:198-206.
18. NAKAMOTO Y, TATSUMI M, HAMMOUD D, et al. Normal FDG distribution patterns in the head and neck: PET/CT evaluation. Radiology 2005;234:879-85.
19. ANZAI Y, CARROL Wr, QUINT Dj, et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-fluoro-D- glucose PET and MR imaging diagnoses. Radiology 1996;200:135-41.
20. STOKKEL Mp, TERHAARD Ch, HORDIJK Gj, et al. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography. Eur J Nuc Med 1999;26:767-73
21. KUBOTA K, YOKOYAMA J, YAMAGUCHi K, et al. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT. Eur J Nucl Med Mol Imaging 2004;31:590-5.
22. YAO M, GRAHAM Mm, SMITH Rb, et al. Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment: a preliminary report. Int J Radiat Oncol Biol Phys 2004;60:1410-8.
23. PORCEDDU Sv, JARMOLOWSKI E, HICKS Rj, et al. Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo) radiotherapy in head and neck cancer. Head Neck 2005;27:175-81.
24. ROGERS Jw, GREVEN Km, MCGUIRT Wf, et al. Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have negative PET scan after definitive radiation therapy? Int J Radiat Oncol Biol Phys 2004;58:694-7.
25. MCCOLLUM Ad, BURRELL Sc, HADDAD Ri, et al. Positron emission tomography with 18F-Fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotheray in head and neck cancer. Head Neck 2004;26:890-6.